Cargando…
Mortality in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes does not depend on levetirazetam alone
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629319/ https://www.ncbi.nlm.nih.gov/pubmed/31205119 http://dx.doi.org/10.1097/CM9.0000000000000163 |
Ejemplares similares
-
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) in the 18th Century: Mitochondrial Disorders Are Not of Recent Origin
por: Hayman, John, et al.
Publicado: (2022) -
Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
por: Fan, Hueng-Chuen, et al.
Publicado: (2021) -
Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
por: Li, Jiaai, et al.
Publicado: (2021) -
MRI Features of Stroke-Like Episodes in Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes
por: Cheng, Weiqin, et al.
Publicado: (2022) -
Neurofilament light is a novel biomarker for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
por: Zheng, Yong-Sheng, et al.
Publicado: (2021)